Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19

• Päätekijät: Si-Hyuck Kang (Tekijä), Dong-Hoon Lee (Tekijä), Kyung-Do Han (Tekijä), Jin-Hyung Jung (Tekijä), Sang-Hyun Park (Tekijä), Andrew M. Dai (Tekijä), Henry G. Wei (Tekijä), Chang-Hwan Yoon (Tekijä), Tae-Jin Youn (Tekijä), In-Ho Chae (Tekijä), Cheol-Ho Kim (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2021-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background There have been concerns regarding the safety of renin-angiotensin-aldosterone-system (RAAS)-blocking agents including angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) during the coronavirus disease 2019 (COVID-19) pandemic. This study sough...